NEW YORK (GenomeWeb News) – Epigenomics yesterday reported that its third-quarter revenues bolted up over 250 percent and its net loss declined around 10 percent year over year.

The German molecular diagnostics firm reported total revenues of €1.2 million (US$1.8 million) over the three-month period ended Sept. 30, up from €320,000 for the third quarter of 2008.

Epigenomics' net loss for the third quarter fell to €2.3 million from €2.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.